2023-24年季节性流感疫苗效果中期估计——美国
美国2023-24流感季采用检测阴性病例对照设计,利用四个疫苗效果网络数据估计≥6月龄就诊者的流感疫苗效果。6月龄-17岁儿童门诊就诊疫苗效果为59%-67%、住院为52%-61%;≥18岁成人门诊为33%-49%、住院为41%-44%。结论认为2023-24季节性流感疫苗可有效降低医疗就诊流感病毒感染风险,CDC推荐所有≥6月龄未接种者在本季当地流感流行期间接种。
要点
- 6月龄-17岁儿童门诊就诊流感疫苗效果为59%-67%,住院为52%-61%。
- ≥18岁成人门诊就诊流感疫苗效果为33%-49%,住院为41%-44%。
- CDC推荐所有≥6月龄且本季尚未接种者,在当地流感流行期间接种疫苗。
核心结论
- 2023-24季节性流感疫苗可有效降低医疗就诊流感病毒感染风险。
- CDC推荐所有≥6月龄且本季尚未接种者,在当地流感流行期间接种疫苗。
研究设计与样本
- 采用检测阴性病例对照研究设计,利用2023-24流感季四个疫苗效果网络的数据。
- 研究对象为≥6月龄因急性呼吸道疾病就医的患者。
主要发现
- 6月龄-17岁儿童和青少年中,针对流感相关门诊就诊的疫苗效果为59%-67%,针对流感相关住院的疫苗效果为52%-61%。
- ≥18岁成人中,针对流感相关门诊就诊的疫苗效果为33%-49%,针对住院的疫苗效果为41%-44%。
- 儿童和青少年中针对甲型流感的疫苗效果在不同就医场景下为46%-59%,成人为27%-46%。
- 门诊场景下儿童患者针对乙型流感的疫苗效果为64%-89%,所有成人不同就医场景下为60%-78%。
临床怎么用
- CDC推荐所有≥6月龄且本季尚未接种流感疫苗者,在当地流感流行期间接种疫苗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the United States, annual influenza vaccination is recommended for all persons aged ≥6 months. Using data from four vaccine effectiveness (VE) networks during the 2023-24 influenza season, interim influenza VE was estimated among patients aged ≥6 months with acute respiratory illness-associated medical encounters using a test-negative case-control study design. Among children and adolescents aged 6 months-17 years, VE against influenza-associated outpatient visits ranged from 59% to 67% and against influenza-associated hospitalization ranged from 52% to 61%. Among adults aged ≥18 years, VE against influenza-associated outpatient visits ranged from 33% to 49% and against hospitalization from 41% to 44%. VE against influenza A ranged from 46% to 59% for children and adolescents and from 27% to 46% for adults across settings. VE against influenza B ranged from 64% to 89% for pediatric patients in outpatient settings and from 60% to 78% for all adults across settings. These findings demonstrate that the 2023-24 seasonal influenza vaccine is effective at reducing the risk for medically attended influenza virus infection. CDC recommends that all persons aged ≥6 months who have not yet been vaccinated this season get vaccinated while influenza circulates locally.
引用
- Frutos AM, Price AM, Harker E, et al. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38421935. doi:10.15585/mmwr.mm7308a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。